1. A company is in the process of inventing a Covid-19 vaccine. There is serious disagreement on whether the company should move straight into commercial production without a clinical trial or conduct clinical trial before moving into commercial production. The available data indicates that releasing the product unto the market has 5% of failure with an impact of 20,000,000 when clinical trials is done. Whereas failure to do clinical trials has 98.55 of failure with an impact of 900,000,000. Should there be success in both scenarios there will be no impact. Please note that the cost of conducting clinical trial is 150,000,000.Using Estimated Monetary Value (EMV) and Decision Tree Analysis as a Project Manager:
2. Construct a Decision Tree for the above case(10 marks)

1. Evaluate the options available and advice your project sponsor on the best option based on the data provided(10 marks)